GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dechra Pharmaceuticals director steps down after 12 years

Mon, 27th Nov 2023 08:44

(Alliance News) - Dechra Pharmaceuticals PLC on Monday said Director Tony Griffin has stepped down after 12 years in the role, effective immediately.

The Northwich, Cheshire-based veterinary drugmaker said Griffin will also retire from his role as managing director of DVP Europe.

Dechra did not give a reason for his departure.

Chief Executive Officer Ian Page said: "I would like to take this opportunity to thank Tony for the significant contribution that he has made to the group during his tenure. Tony joined us following the acquisition of Eurovet in 2013. This was a transformative acquisition, providing critical mass, new markets, a wide range of complementary products and additional expertise to our management team."

Shares in Dechra were up 0.1% at 3,824.00 pence each in London on Monday morning.

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Jun 2021 08:45

LONDON MARKET OPEN: FTSE 100 boosted by ICG and BAT; DAX trails behind

LONDON MARKET OPEN: FTSE 100 boosted by ICG and BAT; DAX trails behind

Read more
8 Jun 2021 08:28

Dechra Pharmaceuticals says annual revenue to beat market expectations

Dechra Pharmaceuticals says annual revenue to beat market expectations

Read more
8 Jun 2021 07:52

LONDON MARKET PRE-OPEN: BAT and Dechra both lift revenue outlook

LONDON MARKET PRE-OPEN: BAT and Dechra both lift revenue outlook

Read more
8 Jun 2021 07:30

Dechra Pharmaceuticals FY revenue to beat market expectations

(Sharecast News) - Dechra Pharmaceuticals said on Tuesday that full-year revenue was set to be ahead of consensus expectations, as it continues to benefit from strong market fundamentals and lower costs.

Read more
16 Apr 2021 16:10

Director dealings: Dechra director lowers stake

(Sharecast News) - Dechra Pharmaceuticals revealed on Friday that director Tony Griffin had sold 25,000 ordinary shares in the FTSE 250-listed veterinary drugmaker.

Read more
16 Apr 2021 15:17

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

Read more
31 Mar 2021 18:46

EXECUTIVE CHANGES: eve Sleep picks new chair; Sopheon promotes new CEO

EXECUTIVE CHANGES: eve Sleep picks new chair; Sopheon promotes new CEO

Read more
31 Mar 2021 16:15

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
11 Mar 2021 13:28

Thursday broker round-up

(Sharecast News) - Hunting: RBC Capital Markets downgrades to sector perform with a target price of 305p.

Read more
11 Mar 2021 09:40

BROKER RATINGS: BofA, Barclays and Goldman start Dr Martens coverage

BROKER RATINGS: BofA, Barclays and Goldman start Dr Martens coverage

Read more
2 Mar 2021 09:40

BROKER RATINGS: Prudential, Pennon and Royal Mail get upgrades

BROKER RATINGS: Prudential, Pennon and Royal Mail get upgrades

Read more
26 Feb 2021 13:47

Friday broker round-up

(Sharecast News) - Reckitt Benckiser: Credit Suisse reiterates outperform with a target price of 7,800p.

Read more
26 Feb 2021 09:33

BROKER RATINGS: JPMorgan Downgrades Entain To Neutral

BROKER RATINGS: JPMorgan Downgrades Entain To Neutral

Read more
25 Feb 2021 16:15

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
23 Feb 2021 09:31

BROKER RATINGS: JPMorgan Starts Smurfit Kappa With Overweight

BROKER RATINGS: JPMorgan Starts Smurfit Kappa With Overweight

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.